|Posted on November 5, 2017 at 9:35 AM|
Many recipients of the flu vaccine have suffered serious adverse events. In 1976, the US public was first alerted to the risk of Guillian-Barre and death after the CDC's massive swine flu vaccine campaign. Of the 40 million Americans who received the vaccine, at least 4000 recipients of that vaccine suffered serious adverse events, including Guillain-Barre. Many vaccine recipients were hospitalized, some were permanently handicapped, and as many as 300 died. The cost to the taxpayers included $3.5 billion in vaccine injury damages.
We now know that the swine flu "epidemic" simply never happened and that the American public was left with a huge bill, along with approximately 4000 citizens left handicapped or dead. Sadly, it seems that the government did not learn the lessons of 1976; trouble resurfaced in 2009 when the H1N1 swine flu scare commenced.
The WHO began an active, visible swine flu scare campaign, which distorted public health priorities across Europe and wasted vast amounts of public funds to stockpile vaccines and antiverals. The declaration of the pandemic also led to accelerated vaccine approvals. Scientists have blamed a resulting inadequately researched vaccine, Pandemrix, for permanent cases of narcolepsy in children aged five to fifteen in Iceland and Ireland.
After the 2009 non-pandemic, the overstock of flu vaccines and doses of the antiviral Tamiflu in national stockpiles prompted the Parliamentary Assembly of the Council of Europe (PACE) to undertake an investigation into the undisclosed financial ties between the WHO, ESWI, GlaxoSmithKline, and Roche. PACE's report highlighted the extent to which industry interests had hijacked public health. A few independent scientists, including Dr Thomas Jefferson of The Cochrane Collaboration and Dr Wolfgang Wodarg of PACE, condemned the behavior of those promoting vaccines for financial gain. They accused the WHO of fueling excessive fear and pushing many European governments to stockpile unnecessary vaccines and antivirals.
Toni Bark, MD, MHEM, LEED AP
Categories: Vax Facts